Back
Apogee Therapeutics 10K Form
Sell
38
APGE
Apogee Therapeutics
Last Price:
44.51
Seasonality Move:
208.29%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive APGE News And Ratings
See the #1 stock for the next 7 days that we like better than APGE
APGE Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-43.28M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $12.91 |
| Price / Book: | 3.45 |
Profitability
| EPS (TTM): | -2.75410 |
|---|---|
| Net Income (TTM): | $-146.66M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Apogee Therapeutics Earnings Forecast
Key Apogee Therapeutics Financial Ratios
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 2 years have been positive in 0 years.
Apogee Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | APGE |
| Website: | apogeetherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
APGE Technical Analysis vs Fundamental Analysis
Sell
38
Apogee Therapeutics (APGE)
is a Sell
Is Apogee Therapeutics a Buy or a Sell?
-
Apogee Therapeutics stock is rated a Sell
The current Apogee Therapeutics [APGE] share price is $44.50. The Score for APGE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.